Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
letter
. 1963 Jul 13;89(2):82–83.

Topical Application of Flurandrenolone in the Treatment of Atopic Dermatitis

Peter J Feher, Anthony Graham, Frederick Kalz
PMCID: PMC1921606  PMID: 13944702

Abstract

The effect of flurandrenolone, 0.05%, in a cream base was compared with that of hydrocortisone, 1%, in the same base in 35 cases of atopic dermatitis, using contralateral application technique. The efficacy of flurandrenolone was found to be superior to that of hydrocortisone in 23 instances and equal in 12 cases. A fourfold dilution of this cream, flurandrenolone 0.0125%, was compared with 1% hydrocortisone cream in 18 patients and similar results were obtained. The superiority of flurandrenolone was particularly evident during the first week of application. The therapeutic efficacy of small amounts of flurandrenolone results in economic advantage to the patient and enables him to use applications of this preparation more freely.

Full text

PDF
82

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLANK H. Clinical trials, a scientific discipline. J Invest Dermatol. 1961 Oct;37:235–240. [PubMed] [Google Scholar]
  2. POLANO M. K. Triamcinolone acetonide cream in a double-blind test. Arch Dermatol. 1961 Feb;83:214–216. doi: 10.1001/archderm.1961.01580080044004. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES